Flow diagram. حسب Cristina Dolciotti (16317330)

الموضوعات:

Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl... حسب Vidya G. Bettada (22208808)

"…(c) Vitamin D3 and the positive control Cisplatin differently modulated FBG in hyperglycaemic mice: Intraperitoneal administration of vitamin D3 very minimally decreased FBG compared to vehicle control at the end of the study. …"

Control (Ctrl) STZ mice show changes in glomerular morphology. حسب Andrey V. Cybulsky (4007012)

الموضوعات:

Control (Ctrl) GECs are more susceptible to injury compared to iPLA₂γ KO GECs. حسب Andrey V. Cybulsky (4007012)

الموضوعات:

iPLA₂γ KO mice show increased glomerular autophagy. حسب Andrey V. Cybulsky (4007012)

الموضوعات:

Podocyte numbers in control and iPLA₂γ KO mice (WT1-positive cells). حسب Andrey V. Cybulsky (4007012)

الموضوعات:

STZ increases glomerular matrix expansion. حسب Andrey V. Cybulsky (4007012)

الموضوعات:

Receiver operating characteristic curve analyses for the prediction of hepatitis C. حسب Lu Han (151620)

الموضوعات:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. حسب Masashi Okawa (8951294)

الموضوعات:

The characteristics and clinical features of 12 patients. حسب Masashi Okawa (8951294)

الموضوعات:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. حسب Masashi Okawa (8951294)

الموضوعات:

Exploring the correlation between systemic inflammation biomarkers and HCV infection (logarithm base 2). حسب Lu Han (151620)

الموضوعات:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. حسب Masashi Okawa (8951294)

الموضوعات:

Threshold effect analysis of systemic inflammatory biomarkers on hepatitis C using two-piece wise linear regression. حسب Lu Han (151620)

الموضوعات:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. حسب Masashi Okawa (8951294)

الموضوعات:

The original data for the figures. حسب Masashi Okawa (8951294)

الموضوعات:

Exclusion and enrollment summary from NHANES. حسب Lu Han (151620)

الموضوعات:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. حسب Masashi Okawa (8951294)

الموضوعات:

Demographic information and baseline population characteristics. حسب Lu Han (151620)

الموضوعات: